{"id":"https://openalex.org/W7225428506","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1189","title":"1189 A phase 1/1b study of the tumor-activated IL-2 prodrug WTX-124 alone or in combination with pembrolizumab in adults with relapsed/refractory, advanced/metastatic, immunotherapy-sensitive solid tumors","display_name":"1189 A phase 1/1b study of the tumor-activated IL-2 prodrug WTX-124 alone or in combination with pembrolizumab in adults with relapsed/refractory, advanced/metastatic, immunotherapy-sensitive solid tumors","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225428506","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1189"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.1189","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1189","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1189","pdf_url":"https://jitc.bmj.com/content/14/Suppl_3/A1405.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Late-Breaking Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_3/A1405.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082674870","display_name":"Justin C. Moser","orcid":"https://orcid.org/0000-0002-0643-6759","observed_orcids":["https://orcid.org/0000-0002-0643-6759"]},"institutions":[{"id":"https://openalex.org/I4210130412","display_name":"HonorHealth","ror":"https://ror.org/03szbwj17","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130412"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin Moser","raw_affiliation_strings":["HonorHealth Research Instittue, Scottsdale, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HonorHealth Research Instittue, Scottsdale, AZ, USA","institution_ids":["https://openalex.org/I4210130412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037104512","display_name":"Hans-Joerg Hammers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hans Hammers","raw_affiliation_strings":["University of Texas Southwestern Medical Center, Dallas, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern Medical Center, Dallas, TX, USA","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034641387","display_name":"Rohan Maniar","orcid":"https://orcid.org/0000-0002-6089-2237","observed_orcids":["https://orcid.org/0000-0002-6089-2237"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]},{"id":"https://openalex.org/I4390039234","display_name":"Indiana University Melvin and Bren Simon Comprehensive Cancer Center","ror":"https://ror.org/00g1d7b60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039234","https://openalex.org/I592451"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rohan Maniar","raw_affiliation_strings":["Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I4388446366","https://openalex.org/I4390039234","https://openalex.org/I4394709130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035539932","display_name":"Sunandana Chandra","orcid":"https://orcid.org/0000-0001-7936-5069","observed_orcids":["https://orcid.org/0000-0001-7936-5069"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sunandana Chandra","raw_affiliation_strings":["Northwestern University, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University, Chicago, IL, USA","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109694524","display_name":"Ismael Rodriguez Rivera","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ismael Rodriguez Rivera","raw_affiliation_strings":["NEXT Oncology, San Antonio, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NEXT Oncology, San Antonio, TX, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049071296","display_name":"Mehmet As\u0131m Bilen","orcid":"https://orcid.org/0000-0003-4003-1103","observed_orcids":["https://orcid.org/0000-0003-4003-1103"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehmet A Bilen","raw_affiliation_strings":["Winship Cancer Institute of Emory University, Atlanta, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winship Cancer Institute of Emory University, Atlanta, GA, USA","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020955148","display_name":"Ahmad A. Tarhini","orcid":"https://orcid.org/0000-0002-3193-9702","observed_orcids":["https://orcid.org/0000-0002-3193-9702"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmad A Tarhini","raw_affiliation_strings":["H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029588412","display_name":"Brendan D. Curti","orcid":"https://orcid.org/0000-0003-3948-2708","observed_orcids":["https://orcid.org/0000-0003-3948-2708"]},"institutions":[{"id":"https://openalex.org/I2801670537","display_name":"Providence Portland Medical Center","ror":"https://ror.org/015tmw922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801670537","https://openalex.org/I4210160466","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brendan D Curti","raw_affiliation_strings":["Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA","institution_ids":["https://openalex.org/I2801670537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112593024","display_name":"Mart\u00edn Guti\u00e9rrez","orcid":"https://orcid.org/0000-0003-3156-3159","observed_orcids":["https://orcid.org/0000-0003-3156-3159"]},"institutions":[{"id":"https://openalex.org/I4210148589","display_name":"Hackensack Meridian Health","ror":"https://ror.org/04p5zd128","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210148589"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin Gutierrez","raw_affiliation_strings":["Hackensack Meridian Health, Hackensack, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hackensack Meridian Health, Hackensack, NJ, USA","institution_ids":["https://openalex.org/I4210148589"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040917850","display_name":"Jennifer Margaret Segar","orcid":"https://orcid.org/0000-0002-6345-2093","observed_orcids":["https://orcid.org/0000-0002-6345-2093"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer M Segar","raw_affiliation_strings":["Texas Oncology-Houston Medical Center Next Oncology, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Oncology-Houston Medical Center Next Oncology, Houston, TX, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081361188","display_name":"Amir S. Steinberg","orcid":"https://orcid.org/0000-0001-9627-7546","observed_orcids":["https://orcid.org/0000-0001-9627-7546"]},"institutions":[{"id":"https://openalex.org/I1321686444","display_name":"Westchester Medical Center","ror":"https://ror.org/03fcgva33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1321686444"]},{"id":"https://openalex.org/I181190671","display_name":"New York Medical College","ror":"https://ror.org/03dkvy735","country_code":"US","type":"education","lineage":["https://openalex.org/I181190671"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amir Steinberg","raw_affiliation_strings":["Westchester Medical Center/New York Medical College, Valhalla, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Westchester Medical Center/New York Medical College, Valhalla, NY, USA","institution_ids":["https://openalex.org/I1321686444","https://openalex.org/I181190671"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005038640","display_name":"Kulandayan K. Subramanian","orcid":"https://orcid.org/0000-0002-7750-0025","observed_orcids":["https://orcid.org/0000-0002-7750-0025"]},"institutions":[{"id":"https://openalex.org/I4405263496","display_name":"Werewolf Therapeutics (United States)","ror":"https://ror.org/01wrd9933","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263496"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kulandayan K Subramanian","raw_affiliation_strings":["Werewolf Therapeutics Inc., Watertown, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Werewolf Therapeutics Inc., Watertown, MA, USA","institution_ids":["https://openalex.org/I4405263496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112254438","display_name":"Kristin R. Morris","orcid":"https://orcid.org/0009-0006-9102-210X","observed_orcids":["https://orcid.org/0009-0006-9102-210X"]},"institutions":[{"id":"https://openalex.org/I4405263496","display_name":"Werewolf Therapeutics (United States)","ror":"https://ror.org/01wrd9933","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263496"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristin Morris","raw_affiliation_strings":["Werewolf Therapeutics Inc., Watertown, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Werewolf Therapeutics Inc., Watertown, MA, USA","institution_ids":["https://openalex.org/I4405263496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022989853","display_name":"Saero Park","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405263496","display_name":"Werewolf Therapeutics (United States)","ror":"https://ror.org/01wrd9933","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263496"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saero Park","raw_affiliation_strings":["Werewolf Therapeutics Inc., Watertown, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Werewolf Therapeutics Inc., Watertown, MA, USA","institution_ids":["https://openalex.org/I4405263496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070916112","display_name":"Matt Chapman-Rounds","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matt Chapman-Rounds","raw_affiliation_strings":["Cogitars GmbH, Heidelberg, Baden-W\u00fcrttemberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cogitars GmbH, Heidelberg, Baden-W\u00fcrttemberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031926846","display_name":"RANDI E. ISAACS","orcid":"https://orcid.org/0000-0003-0433-8976","observed_orcids":["https://orcid.org/0000-0003-0433-8976"]},"institutions":[{"id":"https://openalex.org/I4405263496","display_name":"Werewolf Therapeutics (United States)","ror":"https://ror.org/01wrd9933","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263496"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Randi E Isaacs","raw_affiliation_strings":["Werewolf Therapeutics Inc., Watertown, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Werewolf Therapeutics Inc., Watertown, MA, USA","institution_ids":["https://openalex.org/I4405263496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102747606","display_name":"Sameer S Chopra","orcid":"https://orcid.org/0000-0002-7969-0555","observed_orcids":["https://orcid.org/0000-0002-7969-0555"]},"institutions":[{"id":"https://openalex.org/I4405263496","display_name":"Werewolf Therapeutics (United States)","ror":"https://ror.org/01wrd9933","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263496"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sameer S Chopra","raw_affiliation_strings":["Werewolf Therapeutics Inc., Watertown, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Werewolf Therapeutics Inc., Watertown, MA, USA","institution_ids":["https://openalex.org/I4405263496"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049243227","display_name":"Igor J. Puzanov","orcid":"https://orcid.org/0000-0002-9803-3497","observed_orcids":["https://orcid.org/0000-0002-9803-3497"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Igor Puzanov","raw_affiliation_strings":["Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA","institution_ids":["https://openalex.org/I1292894508"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":14,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1405","last_page":"A1405"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9750000238418579},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-combination-therapy","display_name":"immune checkpoint inhibitor combination","score":0.593999981880188},{"id":"https://openalex.org/keywords/relapsed-refractory-solid-tumors","display_name":"relapsed/refractory solid tumors","score":0.9179999828338623},{"id":"https://openalex.org/keywords/metastatic-solid-tumors","display_name":"metastatic solid tumors","score":0.8259999752044678}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.868399977684021},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.8192999958992004},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6615999937057495},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5181999802589417},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4390000104904175},{"id":"https://openalex.org/C2993640289","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Solid tumor","level":3,"score":0.3896999955177307},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.3743000030517578},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.3296999931335449},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2944999933242798},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.29109999537467957},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2881999909877777},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.25949999690055847},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.25609999895095825}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.1189","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1189","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1189","pdf_url":"https://jitc.bmj.com/content/14/Suppl_3/A1405.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Late-Breaking Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.1189","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1189","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1189","pdf_url":"https://jitc.bmj.com/content/14/Suppl_3/A1405.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Late-Breaking Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309381","display_name":"Emory University","ror":"https://ror.org/03czfpz43"},{"id":"https://openalex.org/F4320309475","display_name":"Northwestern University","ror":"https://ror.org/000e0be47"},{"id":"https://openalex.org/F4320310169","display_name":"University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225428506.pdf","grobid_xml":"https://content.openalex.org/works/W7225428506.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388075693","https://openalex.org/W4365512249","https://openalex.org/W4399662709","https://openalex.org/W2995870482","https://openalex.org/W4224274268","https://openalex.org/W7225299420","https://openalex.org/W4220767421","https://openalex.org/W4404053122","https://openalex.org/W3213880233","https://openalex.org/W4282944927"],"abstract_inverted_index":{"Background":[0],"Patients":[1,86],"who":[2,80,428],"progress":[3],"on":[4],"or":[5,71,192,292],"are":[6],"intolerant":[7],"of":[8,36,131,175,323,337,347,360,413],"immune":[9],"checkpoint":[10],"inhibitors":[11],"(ICIs)":[12],"have":[13],"an":[14],"unmet":[15],"need":[16],"that":[17,336],"could":[18],"be":[19],"addressed":[20],"by":[21,442],"IL-2":[22,39,341,399],"therapy.":[23,141],"WTX-124":[24,62,140,260,332,363,394,414],"is":[25,423],"a":[26,48,56,68,178,189],"systemically":[27],"administered,":[28],"half-life":[29],"extended":[30],"prodrug":[31,392],"engineered":[32],"to":[33,78,232,425,519],"enhance":[34],"exposure":[35,334,346,400],"wild":[37],"type":[38],"selectively":[40],"in":[41,228,406,430,522],"tumors.":[42,407],"Here":[43],"we":[44],"present":[45],"data":[46,276,313,409],"from":[47],"completed":[49],"Phase":[50],"1/1b":[51],"study":[52,438],"(":[53],"NCT05479812).Methods":[54],"In":[55,142,236,262,510],"dose":[57,117,340],"escalation/expansion":[58],"(Parts":[59],"A,":[60,172,224,238],"B),":[61,173],"was":[63,150,269,285,307,366,440],"administered":[64],"IV":[65,75],"Q2W":[66],"as":[67,152,452],"monotherapy":[69],"(mono)":[70,319],"with":[72,87,259,325,343,390],"pembrolizumab":[73],"400mg":[74],"Q6W":[76],"(combo)":[77,322],"patients":[79,136,176,295,324,417,513],"previously":[81],"received":[82,139],"\u22651":[83],"ICI":[84,298],"regimen.":[85],"cutaneous":[88,90],"melanoma,":[89,246],"squamous":[91],"cell":[92,98,104],"cancer":[93,100],"(CSCC),":[94],"PD-L1":[95],"+":[96],"non-small":[97],"lung":[99],"(NSCLC)":[101],"and":[102,119,210,230,248,320,369],"renal":[103],"carcinoma":[105],"(RCC)":[106],"were":[107,200,226,254,384],"eligible":[108],"for":[109,155,216,294,386,416],"Part":[110,143,237,263],"B.":[111],"Primary":[112],"endpoints":[113,127],"included":[114,128,241],"safety,":[115],"recommended":[116],"(RD)":[118],"overall":[120],"response":[121],"rate":[122],"(ORR)":[123],"per":[124],"RECIST.":[125],"Secondary":[126],"pharmacokinetics/pharmacodynamics.Results":[129],"As":[130],"April":[132],"6,":[133],"2026,":[134],"155":[135],"aged":[137],"23-96":[138],"A":[144],"(n":[145,168,220,300,354],"=":[146,162,169,221,279,290,301,316,355],"65),":[147],"18":[148,165,217,330,364],"mg":[149,166,218,365],"selected":[151],"the":[153,265,443,523],"RD":[154],"both":[156],"mono,":[157,387],"combo":[158,219,267],"(0":[159],"DLTs,":[160],"n":[161,278,289,315],"15).":[163],"At":[164,329],"mono":[167,233,283,305,377],"58,":[170],"Parts":[171,223],"29%":[174],"had":[177,327,370],"Grade":[179],"3":[180],"(G3)":[181],"treatment-related":[182],"adverse":[183],"event":[184],"(TRAE).":[185],"No":[186],"patient":[187,427],"developed":[188],"G4/G5":[190],"TRAE":[191],"vascular":[193],"leak":[194],"syndrome.":[195],"The":[196,281,303,408,421,437],"most":[197],"frequent":[198],"TRAEs":[199,215],"arthralgia":[201],"(G1-2":[202],"63.8%,":[203],"G3":[204],"6.9%),":[205],"fatigue":[206],"(34.5%,":[207],"all":[208,213,253,512],"G1-2)":[209],"pruritis":[211],"(31%,":[212],"G1-2).":[214],"47,":[222],"B)":[225],"similar":[227,385],"character":[229],"severity":[231],"(G3":[234],"32%).":[235],"confirmed":[239,274,311],"responses":[240],"two":[242,273],"CRs":[243],"(CSCC,":[244],"mono;":[245],"combo)":[247],"one":[249],"PR":[250],"(melanoma,":[251],"combo);":[252],"ongoing":[255],">21":[256],"months,":[257],"even":[258],"discontinuation.":[261],"B,":[264],"NSCLC":[266],"ORR":[268,284,306],"37.5%":[270],"(3":[271,287],"PRs,":[272,288],"after":[275,312],"cutoff,":[277,314],"8).":[280,317],"melanoma":[282],"15.8%":[286],"19)":[291],"33.3%":[293],"without":[296],"primary":[297],"resistance":[299],"9).":[302],"CSCC":[304],"12.5%":[308],"(1":[309],"CR,":[310],"52.6%":[318],"70.6%":[321],"RCC":[326],"SD.":[328],"mg,":[331],"plasma":[333,397],"exceeded":[335],"approved":[338,441],"high":[339],"but":[342],"~145-fold":[344],"less":[345],"free":[348,398],"(active)":[349],"IL-2.":[350],"Paired":[351],"tumor":[352],"biopsies":[353],"27)":[356],"showed":[357],"dose-dependent":[358],"upregulation":[359],"T-cell/activation":[361],"genes.Conclusions":[362],"well":[367],"tolerated":[368],"clinical":[371,432,450],"activity":[372],"(combo":[373],"ORR,":[374,378],"NSCLC:":[375],"37.5%;":[376],"non-primary":[379],"ICI-resistant":[380],"melanoma:":[381],"33.3%).":[382],"Toxicities":[383],"combo.":[388],"Consistent":[389],"its":[391],"mechanism,":[393],"produced":[395],"low":[396],"at":[401,447],"doses":[402],"causing":[403],"T-cell":[404],"activation":[405],"support":[410],"further":[411],"development":[412],"therapy":[415],"following":[418],"SOC":[419],"ICIs.Acknowledgements":[420],"Sponsor":[422],"grateful":[424],"each":[426,448],"participated":[429],"this":[431],"trial.Trial":[433],"Registration":[434],"NCT05479812Ethics":[435],"Approval":[436],"protocol":[439,459,479],"institutional":[444],"review/ethics":[445],"board":[446],"participating":[449],"site":[451],"follows:":[453],"Westchester":[454],"Medical":[455],"Center":[456],"(NYMC":[457],"IRB,":[458,478],"#15668),":[460],"HonorHealth":[461],"(WCG":[462,466,498],"IRB":[463,467,473,483,487,492,499,503,508],"1340851),":[464],"Emory":[465],"1337765),":[468],"NEXT":[469,505],"San":[470],"Antonio":[471],"(Salus":[472,507],"NXSAT21.151),":[474],"Indiana":[475],"University":[476],"(IU":[477],"#15531),":[480],"Providence":[481],"(Providence":[482],"STUDY2022000507),":[484],"Northwestern":[485],"(NU":[486],"STU00218459-MOD0047),":[488],"Roswell":[489],"Park":[490],"(RP":[491],"CR00008134/P-3501023),":[493],"Moffitt":[494],"(Advarra":[495],"Pro00084640),":[496],"Hackensack":[497],"1391028),":[500],"UTSW":[501],"(UTSW":[502],"STU20250072),":[504],"Houston":[506],"NXHOU25.13).":[509],"addition,":[511],"provided":[514],"written":[515],"informed":[516],"consent":[517],"prior":[518],"taking":[520],"part":[521],"study.":[524]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-07T00:00:00"}